Clinical Trial Update: ctDNA Monitoring in Early Breast Cancer

View source ↗

Summary

A clinical trial evaluating circulating tumor DNA (ctDNA) monitoring in patients with early breast cancer is currently recruiting, sponsored by Geneplus-Beijing…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Geneplus-Beijing Co. Ltd. | Conditions: Breast Cancer | Status: RECRUITING